Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLL2-BAG: Sequential Bendamustine, Obinutuzumab, and Venetoclax in CLL
NCT02401503Phase 2Completed
- Sponsor
- German CLL Study Group
- Start
- May 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in chronic lymphocytic leukemia (CLL), sponsored by German CLL Study Group. Started May 2015; status: completed.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02401503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401503.